JUN 19, 2017 2:57 PM PDT

Statin Drugs Linked to Increased Risk of Parkinson's

WRITTEN BY: Carmen Leitch

Research has indicated that statins, used by millions of people to lower cholesterol, do not protect against Parkinson's disease as once thought. Statins are commonly prescribed to lower cholesterol levels, and it had been suggested at one time that they offered some protection against Parkinson’s, a degenerative neurological disorder. However, new work by scientists at Penn State College of Medicine has found that routine use of statins could also be accelerating the onset of symptoms of Parkinson's disease. The work was published in the journal Movement Disorders, and is summarized in the video.

Statins are usually given to people that have high cholesterol and a variety of studies had come to different conclusions when it came to Parkinson’s, the second most common neurodegenerative disease in the U.S. Some research had indicated statin use was coupled with a lower risk of the disease, some research said there was no relationship between the two, while studies done in recent years have begun to show the drug caused an increased risk of Parkinson’s disease.

"One of the reasons that may have explained these prior inconsistent results is that higher cholesterol, the main indication to use statins, has been related to lower occurrence of Parkinson's disease," suggested senior author Xuemei Huang, a Professor of Neurology at Penn State College of Medicine. "This made it hard to know if the statin protective effect was due to the drug or preexisting cholesterol status."

For this work a database of patient claims to insurance companies was analyzed; it compiled data from over 50 million individuals, 22,000 of whom had Parkinson's disease. The researchers went on to select 2,322 patients from that list - those that had been recently diagnosed with Parkinson's. Next, patients that had been taking a statin were identified, and it was determined how long they had been exposed to the drug before the symptoms of Parkinson's disease started.

"Statin use was associated with higher, not lower, Parkinson's disease risk, and the association was more noticeable for lipophilic statins, an observation inconsistent with the current hypothesis that these statins protect nerve cells," Huang explained. "In addition, this association was most robust for use of statins less than two-and-a-half years, suggesting that statins may facilitate the onset of Parkinson's disease."

While this research aligns with other data, it also contradicts some other research. One recently published study suggested that those who halted their statin use were more likely to receive a Parkinson's disease diagnosis.

"Our new data suggests a different explanation," Huang said. "Use of statins may lead to new Parkinson's disease-related symptoms, thus causing patients to stop using statins. We are not saying that statins cause Parkinson's disease, but rather that our study suggests that statins should not be used based on the idea that they will protect against Parkinson's,"

 

Sources: UPI via PSU, AJMC, Movement Disorders

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 19, 2021
Cell & Molecular Biology
Viral RNA Can Hijack the Host by Assuming a tRNA-Like Structure
NOV 19, 2021
Viral RNA Can Hijack the Host by Assuming a tRNA-Like Structure
Many viruses have genomes made of RNA. In human cells, messenger RNA (mRNA) molecules act as intermediates; cellular mac ...
NOV 25, 2021
Microbiology
How Microbes Use Copper to Make an Antibiotic
NOV 25, 2021
How Microbes Use Copper to Make an Antibiotic
Copper is known to have antibacterial properties, and though it's an important chemical for many organisms, it can b ...
NOV 26, 2021
Cell & Molecular Biology
Twin Study Reveals Epigenetic Links to Type 2 Diabetes
NOV 26, 2021
Twin Study Reveals Epigenetic Links to Type 2 Diabetes
Identical twins carry the same genome in their cells, which makes them powerful subjects in the study of human disease. ...
DEC 06, 2021
Microbiology
New Type of Antibiotic Targets the Bacterial Ribosome
DEC 06, 2021
New Type of Antibiotic Targets the Bacterial Ribosome
As pathogenic bacteria continue to evolve and find ways to evade common medications, researchers have been racing to dev ...
JAN 05, 2022
Microbiology
The Interaction of Viral & Host Genes Promotes Evolution in Both Species
JAN 05, 2022
The Interaction of Viral & Host Genes Promotes Evolution in Both Species
Microbes are known for their ability to evolve. Many types of microbes can interact with one another, and easily exchang ...
JAN 14, 2022
Clinical & Molecular DX
No, It's Not Just Insulin That Regulates Blood Sugar
JAN 14, 2022
No, It's Not Just Insulin That Regulates Blood Sugar
  In a research breakthrough, scientists have found a hormone secreted by fat cells that plays a similar role to in ...
Loading Comments...